| Literature DB >> 34941722 |
Carlos Alberto-Silva1, Fernanda Calheta Vieira Portaro2, Roberto Tadashi Kodama2, Halyne Queiroz Pantaleão1, Hidetoshi Inagaki3, Ken-Ichi Nihei4, Katsuhiro Konno5.
Abstract
Venoms of solitary wasps are utilized for prey capture (insects and spiders), paralyzing them with a stinger injection to be offered as food for their larvae. Thus, the identification and characterization of the components of solitary wasp venoms can have biotechnological application. In the present study, the venom components profile of a solitary scoliid wasp, Campsomeriella annulata annulata, was investigated through a comprehensive analysis using LC-MS and -MS/MS. Online mass fingerprinting revealed that the venom extract contains 138 components, and MS/MS analysis identified 44 complete sequences of the peptide components. The peptides are broadly divided into two classes: bradykinin-related peptides, and linear α-helical peptides. Among the components of the first class, the two main peptides, α-campsomerin (PRLRRLTGLSPLR) and β-campsomerin (PRLRRLTGLSPLRAP), had their biological activities evaluated. Both peptides had no effects on metallopeptidases [human neprilysin (NEP) and angiotensin-converting enzyme (ACE)] and acetylcholinesterase (AChE), and had no cytotoxic effects. Studies with PC12 neuronal cells showed that only α-campsomerin was able to enhance cell viability, while β-campsomerin had no effect. It is noteworthy that the only difference between the primary structures from these peptides is the presence of the AP extension at the C-terminus of β-campsomerin, compared to α-campsomerin. Among the linear α-helical peptides, annulatin (ISEALKSIIVG-NH2) was evaluated for its biological activities. Annulatin showed histamine releasing activity from mast cells and low hemolytic activity, but no antimicrobial activities against all microbes tested were observed. Thus, in addition to providing unprecedented information on the whole components, the three peptides selected for the study suggest that molecules present in solitary scoliid wasp venoms may have interesting biological activities.Entities:
Keywords: LC-MS; bradykinin-related peptide; comprehensive analysis; linear α-helical peptide; solitary scoliid wasp; venom
Mesh:
Substances:
Year: 2021 PMID: 34941722 PMCID: PMC8708821 DOI: 10.3390/toxins13120885
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1TIC profile from LC-ESI-MS of venom extracts of Campsomeriella annulata annulata by reverse-phase HPLC using CAPCELL PAK C18 (1.5 × 150 mm) with linear gradient of 5–65% CH3CN/H2O/0.1% formic acid over 20 min at flow rate of 200 μL/min.
On-line mass fingerprinting of crude venom extract from Campsomeriella annulata annulata by LC-ESI-MS.
| Fr. No. | Retention Time (min) | [M + H]+ |
|---|---|---|
| 1 | 0.8–1.5 | 90.054, 112.086, 116.069, 118.085, 120.064, 146.164, 147.075, 148.059, 154.085, 156.076, 175.118, 203.222, 258.108, 752.482 |
| 2 | 1.5–2.0 | 132.101, 138.090, 150.057, 182.080, 245.075, 253.116, 268.102, 284.097, 324.126, 348.067, 664.111 |
| 3 | 2.0–3.0 | 166.085, 269.086, 732.288, 873.461, 911.428, 916.637, 952.596, 1006.514, 1050.563, 1377.700, 1629.831 |
| 4 | 3.0–4.0 | 272.133, 660.387, 911.497, 953.580, 1164.582, 1435.706, 1487.628 |
| 5 | 4.0–5.0 | 205.095, 573.309, 585.367, 642.388, 1085.694, 1227.626, 2741.410, 2913.678, 2927.693, 2941.668, 2981.607, 3025.066 |
| 6 | 5.0–5.6 | 497.400, 771.408, 939.662, 1148.716, 1423.836, 2218.047 |
| 7 | 5.6–6.1 | 378.163, 487.319, 728.497, 1418.844, 1439.702, 1548.844, 5297.517, 6211.754 |
| 8 | 6.1–6.3 | 403.251, 555.356, 656.346, 1074.574, 1127.483, 1265.684, 1447.679, 1719.983 |
| 9 | 6.3–6.8 | 753.455, 969.590, 1105.569, 1534.865, 1587.776, 2068.808, 2229.234, 3251.858 |
| 10 | 6.8–7.1 | 419.237, 638.392, 1056.622, 1247.703, 1702.955 |
| 11 | 7.1–7.7 | 1060.438, 1378.768, 2208.189, 3015.057, 3251.857 |
| 12 | 7.7–8.3 | 918.474, 1499.748, 3152.777, 4089.223 |
| 13 | 8.3–8.6 | 900.542, 1128.687, 1182.607, 1250.760, 1266.756, 1500.731, 2244.169, 4716.118 |
| 14 | 8.6–9.0 | 813.492, 1072.654, 1258.713, 2913.497 |
| 15 | 9.0–10.0 | 1365.787, 1452.818, 1902.932, 2765.478 |
| 16 | 10.0–11.0 | 918.557, 995.474, 1281.875, 1415.896, 1840.016, 1893.933 |
| 17 | 11.0–11.8 | 1274.625, 1593.932, 1645.945, 1689.987, 3640.506 |
| 18 | 11.8–12.3 | 1761.009, 1991.029, 2043.940, 2091.104, 2291.182 |
| 19 | 12.3–12.7 | 1324.985, 1689.951 |
| 20 | 12.7–13.8 | 1317.740, 1518.891, 1856.998, 1909.904 |
Amino acids in the crude venom extract from Campsomeriella annulata annulata by LC-ESI-MS.
| RT | Intensity | [M + H]+ | Elemental Composition | Iminium Ion | Elemental Composition | Compound |
|---|---|---|---|---|---|---|
| 1.07 | 50 | 156.076 | C6H10N3O2 | — | Histidine | |
| 140 | 175.118 | C6H15N4O2 | — | Arginine | ||
| 1.28 | 24 | 90.054 | C3H7NO2 | — | Alanine | |
| 18 | 120.064 | C4H10NO3 | — | Threonine | ||
| 180 | 147.075 | C5H11N2O3 | — | Glutamine | ||
| 200 | 148.059 | C5H10NO4 | 102.054 | C4H8NO2 | Glutamic acid | |
| 1.34 | 700 | 116.069 | C5H10NO2 | 70.064 | C4H8N | Proline |
| 70 | 118.085 | C5H12NO2 | 72.080 | C4H10N | Valine | |
| 1.55 | 13 | 150.057 | C5H12NO2S | 104.052 | C4H10NS | Methionine |
| 1.68 | 180 | 132.101 | C6H14NO2 | 86.096 | C5H12N | L/I * |
| 1.72 | 80 | 182.080 | C9H12NO3 | — | Tyrosine | |
| 2.37 | 180 | 166.085 | C9H12NO2 | 120.080 | C8H10N | Phenylalanine |
| 4.17 | 13 | 205.096 | C11H13N2O2 | — | Tryptophan |
* Either leucine (L) and/or isoleucine (I).
Biogenic amines in the crude venom extract from Campsomeriella annulata annulata by LC-ESI-MS.
| RT | Intensity | [M + H]+ | Elemental | Deamination | Elemental | Compound |
|---|---|---|---|---|---|---|
| 1.01 | 7 | 146.164 | C7H20N3 | — | Spermidine | |
| 1.07 | 12 | 112.086 | C5H10N3 | 95.060 | C5H7N2 | Histamine |
| 6 | 203.222 | C10H27N4 | — | Spermine | ||
| 1.34 | 12 | 154.086 | C8H12NO2 | 137.059 | C8H9O2 | Dopamine |
| 1.61 | 700 | 138.090 | C8H12NO | 121.064 | C8H9O | Tyramine |
Nucleic acids in the crude venom extract from Campsomeriella annulata annulata by LC-ESI-MS.
| RT | Intensity | [M + H]+ | Elemental | Compound |
|---|---|---|---|---|
| 1.21 | 10 | 244.091 | C9H14N3O5 | Cytidine |
| 1.28 | 180 | 258.108 | C10H16N3O5 | Thymidine |
| 1.61 | 100 | 348.068 | C10H15N5O7P | AMP |
| 18 | 664.111 | C21H28N7O14P2 | NAD | |
| 1.68 | 1800 | 268.102 | C10H14N5O4 | Adenosine |
| 1.72 | 8 | 245.075 | C9H13N2O6 | Uridine |
| 1.97 | 90 | 284.097 | C10H14N5O5 | Guanosine |
Peptide sequences analyzed from MS/MS spectra.
| Fr | RT | Intens. | MSMS | Charge | (M + H)+ | Sequence |
|---|---|---|---|---|---|---|
| 1 | 1.23 | 70 | 251.499 | 3+ | 752.482 | SKLHRL-NH2 |
| 2 | 1.95 | 85 | 253.116 | + | 253.116 | SF |
| 3 | 2.09 | 91 | 459.905 | 3+ | 1377.700 | RGPRTYSHGHPL |
| 2.27 | 1500 | 318.204 | 3+ | 952.596 | SLSKLHRL-NH2 | |
| 2.53 | 8 | 304.481 | 3+ | 911.428 | TYSHGHPL | |
| 2.78 | 35 | 366.648 | 2+ | 732.288 | HNAEFD | |
| 4 | 3.06 | 8 | 318.532 | 3+ | 953.580 | SLSKLHRL |
| 3.34 | 72 | 330.697 | 2+ | 660.387 | LSEALK | |
| 3.55 | 330 | 456.253 | 2+ | 911.497 | PRLPRLT | |
| 3.66 | 750 | 479.240 | 3+ | 1435.706 | RDPRTYSHGHPL | |
| 3.80 | 1500 | 388.865 | 3+ | 1164.582 | PRTYSHGHPL | |
| 5 | 4.06 | 42 | 293.187 | 2+ | 585.367 | LSPLR |
| 4.56 | 350 | 287.159 | 2+ | 573.309 | RPPGF | |
| 4.99 | 60 | 321.698 | 2+ | 642.388 | GLSPLR | |
| 6 | 5.18 | 85 | 383.577 | 3+ | 1148.716 | VPSLKSLHRL-NH2 |
| 5.37 | 90 | 386.208 | 2+ | 771.408 | RPPGFTP | |
| 5.60 | 29 | 313.893 | 3+ | 939.662 | LVKQKVLL-NH2 | |
| 7 | 5.79 | 80 | 378.163 | + | 378.163 | DFP |
| 6.00 | 90 | 364.751 | 2+ | 728.495 | LKSLLVG-NH2 | |
| 8 | 6.07 | 8 | 403.251 | + | 403.251 | LTGL |
| 6.26 | 600 | 358.863 | 3+ | 1074.574 | RPPGFTPFR (Thr6-BK) | |
| 9 | 6.41 | 11 | 377.231 | 2+ | 753.455 | RLPGLTP |
| 6.45 | 62,000 | 512.294 | 3+ | 1534.865 | PRLRRLTGLSPLR | |
| 6.74 | 860 | 323.869 | 3+ | 969.590 | PATLPAPFR | |
| 10 | 6.84 | 210 | 416.572 | 3+ | 1247.703 | RLVKPVPFYE |
| 6.94 | 1200 | 352.879 | 3+ | 1056.622 | RLPGLTPFR | |
| 7.02 | 12,000 | 568.324 | 3+ | 1702.955 | PRLRRLTGLSPLRAP | |
| 11 | 7.63 | 85 | 530.723 | 2+ | 1060.438 | HNAEFDAAW |
| 7.67 | 390 | 689.887 | 2+ | 1378.768 | PRLRRLTGLSPL | |
| 12 | 7.80 | 52 | 459.741 | 2+ | 918.474 | RPPGFTPF |
| 13 | 8.57 | 2200 | 564.848 | 2+ | 1128.687 | LSEALKSLLVG-NH2 |
| 14 | 8.72 | 470 | 536.829 | 2+ | 1072.650 | LSEALKSLLV |
| 8.73 | 160 | 407.249 | 2+ | 813.490 | PATLPAPF | |
| 8.84 | 460 | 629.861 | 2+ | 1258.713 | LSEALKSLLVGE | |
| 15 | 9.07 | 45 | 455.934 | 3+ | 1365.787 | DALPRLLPAPFR |
| 9.17 | 31 | 484.945 | 3+ | 1452.818 | DALPRLLPGTPFR | |
| 9.70 | 135 | 634.982 | 3+ | 1902.932 | DTFGPLYDKLHQYLGH-NH2 | |
| 16 | 10.69 | 16 | 427.964 | 3+ | 1281.875 | FLLPLLKGLLVG-NH2 |
| 10.81 | 28 | 472.637 | 3+ | 1415.896 | GLLTDLRKFLLK-NH2 | |
| 10.95 | 16 | 459.783 | 2+ | 918.557 | GLVYLLQL | |
| 17 | 11.72 | 9 | 549.320 | 3+ | 1645.945 | DDGLLTDLRKFLLK-NH2 |
| 18 | 11.92 | 30 | 697.706 | 3+ | 2091.104 | HPDDDDDFLLPLLKGLLVG-NH2 |
| 12.01 | 1600 | 664.348 | 3+ | 1991.029 | DDDDDGLLTDLRKFLLK-NH2 | |
| 20 | 13.11 | 1050 | 619.669 | 3+ | 1856.992 | DDDDDFLLPLLKGLLVG-NH2 |
Classification of the peptide sequences.
| RT | Intensity | (M + H)+ | Sequence |
|---|---|---|---|
|
| |||
| 4.56 | 350 | 573.309 | RPPGF |
| 5.37 | 90 | 771.408 | RPPGFTP |
| 7.80 | 52 | 918.474 | RPPGFTPF |
| 6.26 | 600 | 1074.574 | RPPGFTPFR (Thr6-BK) |
| 6.41 | 11 | 753.455 | RLPGLTP |
| 6.94 | 1200 | 1056.622 | RLPGLTPFR (Ca-1056) |
| 8.73 | 160 | 813.490 | PATLPAPF |
| 6.74 | 860 | 969.590 | PATLPAPFR (Ca-969) |
| 9.07 | 45 | 1365.787 | DALPRLLPAPFR (Ca-1365) |
| 9.17 | 31 | 1452.818 | DALPRLLPGTPFR (Ca-1452) |
| 3.55 | 330 | 911.497 | PRLRRLT |
| 7.67 | 390 | 1378.768 | PRLRRLTGLSPL |
| 6.07 | 8 | 403.251 | LTGL |
| 4.06 | 42 | 585.367 | LSPLR |
| 4.99 | 60 | 642.388 | GLSPLR |
| 6.45 | 62,000 | 1534.865 | PRLRRLTGLSPLR (α-campsomerin) |
| 7.02 | 12,000 | 1702.955 | PRLRRLTGLSPLRAP (β-campsomerin) |
|
| |||
| 3.34 | 72 | 660.387 | LSEALK |
| 8.72 | 470 | 1072.650 | LSEALKSLLV |
| 6.00 | 90 | 728.495 | LKSLLVG-NH2 |
| 8.57 | 2200 | 1128.687 | LSEALKSLLVG-NH2 (annulatin) |
| 8.84 | 460 | 1258.713 | LSEALKSLLVGE |
| 10.69 | 16 | 1281.875 | FLLPLLKGLLVG-NH2 (Ca-1281) |
| 13.11 | 1050 | 1856.992 | DDDDDFLLPLLKGLLVG-NH2 |
| 11.92 | 30 | 2091.104 | HPDDDDDFLLPLLKGLLVG-NH2 |
| 10.81 | 28 | 1415.896 | GLLTDLRKFLLK-NH2 (Ca-1415) |
| 11.72 | 9 | 1645.945 | DDGLLTDLRKFLLK-NH2 |
| 12.01 | 1600 | 1991.029 | DDDDDGLLTDLRKFLLK-NH2 |
|
| |||
| 1.23 | 70 | 752.482 | SKLHRL-NH2 |
| 2.27 | 1500 | 952.596 | SLSKLHRL-NH2 |
| 3.06 | 8 | 953.580 | SLSKLHRL |
| 5.18 | 85 | 1148.716 | VPSLKSLHRL-NH2 |
| 2.78 | 35 | 732.288 | HNAEFD |
| 7.63 | 85 | 1060.438 | HNAEFDAAW |
| 2.53 | 8 | 911.428 | TYSHGHPL |
| 3.80 | 1500 | 1164.582 | PRTYSHGHPL |
| 2.09 | 91 | 1377.700 | RGPRTYSHGHPL |
| 3.66 | 750 | 1435.706 | RDPRTYSHGHPL |
| 1.95 | 85 | 253.116 | SF |
| 5.79 | 80 | 378.163 | DFP |
| 10.95 | 16 | 918.557 | GLVYLLQL |
| 5.60 | 29 | 939.662 | LVKQKVLL-NH2 |
| 6.84 | 210 | 1247.703 | RLVKPVPFYE |
| 9.70 | 135 | 1902.931 | DTFGPLYDKLHQYLGH-NH2 |
Bradykinin-related peptides in solitary wasp venoms.
| Peptide | Sequence | References |
|---|---|---|
| Bradykinin (BK) | RPPGFSPFR | [ |
| Thr6-Bradykinin (Thr6-BK) | RPPGFTPFR | [ |
| Megascoliakinin | RPPGFTPFRKA | [ |
| Cyphokinin | DTRPPGFTPFR | [ |
| Fulvonin | SIVLRGKAPFR | [ |
| Cd-146 | SETGNTVTVKGFSPLR | [ |
| α-Scoliidine | DYVTVKGFSPLR | [ |
| β-Scoliidine | DYVTVKGFSPLRKA | [ |
| α-Campsomerin | PRLRRLTGLSPLR | This work |
| β-Campsomerin | PRLRRLTGLSPLRAP | This work |
Figure 2Helical wheel projection of the sequence of annulatin (ISEALKSIIVG-NH2). In this view through the helix axis, the hydrophilic Ser (S), Glu (E), and Lys (K) residues are located on one side and the hydrophobic Ala (A), Ile (I), and Leu (L) residues on the other side of the helix.
Linear α-helical peptides in solitary wasp venoms.
| Peptide | Sequence | References |
|---|---|---|
| Anoplin | GLLKRIKTLL-NH2 | [ |
| Decoralin | SLLSLIRKLIT | [ |
| Eumenitin | LNLKGLFKKVKSLLT | [ |
| Eumenitin-F | LNLKGLFKKVASLLT | [ |
| Eumenitin-R | LNLKGLIKKVASLLN | [ |
| Annulatin | ISEALKSIIVG-NH2 | This work |
Hydrolyses of α-campsomerin and β-campsomerin by NEP and ACE.
| Inhibition | Cleavage | |||
|---|---|---|---|---|
| Peptide | NEP | ACE | NEP | ACE |
| α-campsomerin | <0.01 | <0.01 | <0.01 | <0.01 |
| β-campsomerin | <0.01 | <0.01 | <0.01 | <0.01 |
Figure 3Inhibitory effects of α-campsomerin and β-campsomerin on the activity of acetylcholine esterase (AChE). The extent of AChE activity inhibition was expressed as a percentage of acetylthiocholine iodine substrate hydrolyzed in relation to control (C; blank box). Data from three independent experiments in triplicate are expressed as mean ± standard deviation, and evaluated using one-way ANOVA followed by Tukey’s post-test. * p < 0.05 for differences between the control groups; Tetraethyl pyrophosphate (TEPP; red box).
Figure 4Toxicity of α-campsomerin or β-campsomerin on cell integrity in Vero cells. Cells were treated with peptides 0.1 μmol·L−1 (a), 1 μmol·L−1 (b) and 10 μmol·L−1 (c) for 1, 6, 12, 24, and 48 h. Control and DMSO groups represent cells without treatment and treated with DMSO 5%, respectively. Values are expressed as mean ± SD (n = 3 in triplicate) and analyzed by one-way ANOVA followed by Tukey’s post-test. * p < 0.05 in relation to the control group.
Figure 5Toxicity of α-campsomerin and β-campsomerin on PC12 cell integrity. Cells were treated with peptides 0.1 μmol·L−1 (a), 1 μmol·L−1 (b) and 10 μmol·L−1 (c) for 1, 6, 12, 24, and 48 h. Control and DMSO groups represent cells without treatment and treated with DMSO 5%, respectively. Data were obtained from three independent experiments in triplicate, expressed as mean ± SD, and analyzed by one-way ANOVA followed by Tukey’s post-test. * p < 0.05 compared to the control group; # p < 0.05 compared to the β-campsomerin. Arrows indicate the integrity cells reduced by α-campsomerin, but not β-campsomerin, at 6 h of treatment.
Figure 6Neuroprotective property of α-campsomerin (a) and β-campsomerin (b) on cell integrity of the PC12 cell line against H2O2-induced oxidative stress. PC12 cells were plated at 2 × 104 cells per well in a 96-well plate, and were pre-treated with peptides for 4 h at 37 °C. After that, the medium was replaced containing peptide and H2O2 0.5 mmol·L−1) and incubated for more 20 h. Data are expressed as the mean ± standard deviation from three independent experiments in triplicate and analyzed using one-way ANOVA followed by Dunnett’s post-test. * p < 0.05 for differences between the control and experimental groups.
Antimicrobial, hemolytic, and histamine-releasing activities of annulatin and related peptides.
| MIC a (μmol·L−1) | Hemolytic Activity (%) | Histamine Releasing Activity | ||||
|---|---|---|---|---|---|---|
| at 10 μmol·L−1 | at 12.5 μmol·L−1 | |||||
| Annulatin | Negative | Negative | Negative | - | 15.4 | 33.0 |
| Mastoparan | - | - | - | 13.5 b | - | 31.1 b |
| Melittin | - | - | - | 100.0 b | - | 64.3 b |
a MIC: Minimum Inhibitory Concentration. b The activities from Shigeri et al. [34] were indicated. -: Not determined.